Serveur d'exploration sur l'OCR

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Absorption of oral ethinylestradiol is delayed by its eutectic mixture with cholesterol

Identifieur interne : 003497 ( Main/Exploration ); précédent : 003496; suivant : 003498

Absorption of oral ethinylestradiol is delayed by its eutectic mixture with cholesterol

Auteurs : Vicente Díaz-Sánchez [Mexique] ; Oscar Antúnez [Mexique] ; Lilia Vargas [Mexique] ; Lourdes Boeck [Mexique] ; Marcelo Noguera [Mexique]

Source :

RBID : ISTEX:5C7520721EA3C3E3BF974ADADDED5AC168492EFA

Abstract

A solid dispersion of ethinylestradiol-cholesterol (EE & CHOL; eutectic 1:4 W/W) was prepared by melting and rapid cooling. The fused material was then mixed with lactose as vehicle. Soft gelatin capsules were filled with 50 mg of the final mixture to give 0.050 mg of ethinylestradiol. Six female volunteers received, one capsule of the eutectic combination of EE:CHOL or one 50 μg tablet of ethinylestradiol (Dianor, Syntex), in a cross-over study and in fasting state. Venous blood samples were drawn at 0, 10, 20, 30, 40, 50, 60, 90, 120, 240, 360, 480, 720, 1440 minutes after dosing. Immunoreactive EE was measured by radioimmunoassay to assess the serum concentration-time course. All subjects exhibited a significant increase in EE levels after oral administration. Mean peak EE levels, 1350 pg/ml vs 91 pg/ml (p < 0.001), were achieved 360 minutes and 90 minutes (p < 0.01), after administration of the eutectic and reference formulation, respectively. Eutectic mixture showed a greater area under the serum concentration-time curve, longer mean residence time of the drug in the body, and four times the value of the elimination half-life of the reference formulation. It is concluded that the combination of ethinylestradiol with cholesterol forming an eutectic mixture, when administered orally to normal women, modulates the absorption and the bioavailability of the EE. This approach may be suitable for long-acting oral treatment with sex steroids.

Url:
DOI: 10.1016/0010-7824(91)90125-Y


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Absorption of oral ethinylestradiol is delayed by its eutectic mixture with cholesterol</title>
<author>
<name sortKey="Diaz Sanchez, Vicente" sort="Diaz Sanchez, Vicente" uniqKey="Diaz Sanchez V" first="Vicente" last="Díaz-Sánchez">Vicente Díaz-Sánchez</name>
</author>
<author>
<name sortKey="Antunez, Oscar" sort="Antunez, Oscar" uniqKey="Antunez O" first="Oscar" last="Antúnez">Oscar Antúnez</name>
</author>
<author>
<name sortKey="Vargas, Lilia" sort="Vargas, Lilia" uniqKey="Vargas L" first="Lilia" last="Vargas">Lilia Vargas</name>
</author>
<author>
<name sortKey="Boeck, Lourdes" sort="Boeck, Lourdes" uniqKey="Boeck L" first="Lourdes" last="Boeck">Lourdes Boeck</name>
</author>
<author>
<name sortKey="Noguera, Marcelo" sort="Noguera, Marcelo" uniqKey="Noguera M" first="Marcelo" last="Noguera">Marcelo Noguera</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5C7520721EA3C3E3BF974ADADDED5AC168492EFA</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1016/0010-7824(91)90125-Y</idno>
<idno type="url">https://api.istex.fr/document/5C7520721EA3C3E3BF974ADADDED5AC168492EFA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003424</idno>
<idno type="wicri:Area/Istex/Curation">003169</idno>
<idno type="wicri:Area/Istex/Checkpoint">002706</idno>
<idno type="wicri:doubleKey">0010-7824:1991:Diaz Sanchez V:absorption:of:oral</idno>
<idno type="wicri:Area/Main/Merge">003685</idno>
<idno type="wicri:Area/Main/Curation">003497</idno>
<idno type="wicri:Area/Main/Exploration">003497</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Absorption of oral ethinylestradiol is delayed by its eutectic mixture with cholesterol</title>
<author>
<name sortKey="Diaz Sanchez, Vicente" sort="Diaz Sanchez, Vicente" uniqKey="Diaz Sanchez V" first="Vicente" last="Díaz-Sánchez">Vicente Díaz-Sánchez</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Department of Reproductive Biology, Instituto Nacional de la Nutrición Salvador Zubirán, México city</wicri:regionArea>
<wicri:noRegion>México city</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Antunez, Oscar" sort="Antunez, Oscar" uniqKey="Antunez O" first="Oscar" last="Antúnez">Oscar Antúnez</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Department of Endocrinology, Hospital General de México, SSA, México City</wicri:regionArea>
<wicri:noRegion>México City</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vargas, Lilia" sort="Vargas, Lilia" uniqKey="Vargas L" first="Lilia" last="Vargas">Lilia Vargas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Department of Reproductive Biology, Instituto Nacional de la Nutrición Salvador Zubirán, México city</wicri:regionArea>
<wicri:noRegion>México city</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Boeck, Lourdes" sort="Boeck, Lourdes" uniqKey="Boeck L" first="Lourdes" last="Boeck">Lourdes Boeck</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Department of Reproductive Biology, Instituto Nacional de la Nutrición Salvador Zubirán, México city</wicri:regionArea>
<wicri:noRegion>México city</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Noguera, Marcelo" sort="Noguera, Marcelo" uniqKey="Noguera M" first="Marcelo" last="Noguera">Marcelo Noguera</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Department of Reproductive Biology, Instituto Nacional de la Nutrición Salvador Zubirán, México city</wicri:regionArea>
<wicri:noRegion>México city</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Contraception</title>
<title level="j" type="abbrev">CON</title>
<idno type="ISSN">0010-7824</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">43</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="45">45</biblScope>
<biblScope unit="page" to="53">53</biblScope>
</imprint>
<idno type="ISSN">0010-7824</idno>
</series>
<idno type="istex">5C7520721EA3C3E3BF974ADADDED5AC168492EFA</idno>
<idno type="DOI">10.1016/0010-7824(91)90125-Y</idno>
<idno type="PII">0010-7824(91)90125-Y</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0010-7824</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A solid dispersion of ethinylestradiol-cholesterol (EE & CHOL; eutectic 1:4 W/W) was prepared by melting and rapid cooling. The fused material was then mixed with lactose as vehicle. Soft gelatin capsules were filled with 50 mg of the final mixture to give 0.050 mg of ethinylestradiol. Six female volunteers received, one capsule of the eutectic combination of EE:CHOL or one 50 μg tablet of ethinylestradiol (Dianor, Syntex), in a cross-over study and in fasting state. Venous blood samples were drawn at 0, 10, 20, 30, 40, 50, 60, 90, 120, 240, 360, 480, 720, 1440 minutes after dosing. Immunoreactive EE was measured by radioimmunoassay to assess the serum concentration-time course. All subjects exhibited a significant increase in EE levels after oral administration. Mean peak EE levels, 1350 pg/ml vs 91 pg/ml (p < 0.001), were achieved 360 minutes and 90 minutes (p < 0.01), after administration of the eutectic and reference formulation, respectively. Eutectic mixture showed a greater area under the serum concentration-time curve, longer mean residence time of the drug in the body, and four times the value of the elimination half-life of the reference formulation. It is concluded that the combination of ethinylestradiol with cholesterol forming an eutectic mixture, when administered orally to normal women, modulates the absorption and the bioavailability of the EE. This approach may be suitable for long-acting oral treatment with sex steroids.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Mexique</li>
</country>
</list>
<tree>
<country name="Mexique">
<noRegion>
<name sortKey="Diaz Sanchez, Vicente" sort="Diaz Sanchez, Vicente" uniqKey="Diaz Sanchez V" first="Vicente" last="Díaz-Sánchez">Vicente Díaz-Sánchez</name>
</noRegion>
<name sortKey="Antunez, Oscar" sort="Antunez, Oscar" uniqKey="Antunez O" first="Oscar" last="Antúnez">Oscar Antúnez</name>
<name sortKey="Boeck, Lourdes" sort="Boeck, Lourdes" uniqKey="Boeck L" first="Lourdes" last="Boeck">Lourdes Boeck</name>
<name sortKey="Noguera, Marcelo" sort="Noguera, Marcelo" uniqKey="Noguera M" first="Marcelo" last="Noguera">Marcelo Noguera</name>
<name sortKey="Vargas, Lilia" sort="Vargas, Lilia" uniqKey="Vargas L" first="Lilia" last="Vargas">Lilia Vargas</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/OcrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003497 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003497 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    OcrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5C7520721EA3C3E3BF974ADADDED5AC168492EFA
   |texte=   Absorption of oral ethinylestradiol is delayed by its eutectic mixture with cholesterol
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Sat Nov 11 16:53:45 2017. Site generation: Mon Mar 11 23:15:16 2024